Clinical Characteristics and Antibiotic Utilization in Pediatric Patients Hospitalized With Acute Bacterial Skin and Skin Structure Infection

Pediatric Infectious Disease Journal - United States
doi 10.1097/inf.0000000000000304
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Pharmacokinetic-Pharmacodynamic Analysis for Efficacy of Ceftaroline Fosamil in Patients With Acute Bacterial Skin and Skin Structure Infections

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2014English

Population Pharmacokinetic Analyses for BC-3781 Using Phase 2 Data From Patients With Acute Bacterial Skin and Skin Structure Infections

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2014English

Clinical Measurement Concepts in Acute Skin and Skin Structure Infections and Other Skin Abnormalities: A Comprehensive Literature Review

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Variation in Antibiotic Selection and Clinical Outcomes in Infants <60 Days Hospitalized With Skin and Soft Tissue Infections

Hospital pediatrics
MedicineChild HealthPediatricsPerinatology
2018English

Safety, Tolerability, and Efficacy of GSK1322322 in the Treatment of Acute Bacterial Skin and Skin Structure Infections

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2014English

Emerging Treatment Options for Acute Bacterial Skin and Skin Structure Infections: Focus on Intravenous Delafloxacin

Infection and Drug Resistance
Infectious DiseasesPharmacology
2018English

Oritavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections: An Evidence-Based Review

Core Evidence
MedicineReviewsReferencesPharmacology
2015English

Clinical and Epidemiologic Characteristics of Hospitalized Patients With 2009 H1N1 Influenza Infection

Influenza Research and Treatment
EpidemiologyInfectious DiseasesVirology
2012English

In Vitro Activity of Iclaprim Against Isolates in Two Phase 3 Clinical Trials (REVIVE-1 and -2) for Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy